Fisher Asset Management LLC Grows Stake in Merit Medical Systems, Inc. (NASDAQ:MMSI)

Fisher Asset Management LLC lifted its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) by 1.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 224,181 shares of the medical instruments supplier's stock after purchasing an additional 2,491 shares during the period. Fisher Asset Management LLC owned 0.38% of Merit Medical Systems worth $21,683,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the business. Louisiana State Employees Retirement System grew its position in shares of Merit Medical Systems by 0.4% in the 4th quarter. Louisiana State Employees Retirement System now owns 28,200 shares of the medical instruments supplier's stock worth $2,728,000 after buying an additional 100 shares during the last quarter. Tidal Investments LLC boosted its holdings in Merit Medical Systems by 1.0% in the third quarter. Tidal Investments LLC now owns 10,398 shares of the medical instruments supplier's stock valued at $1,028,000 after acquiring an additional 104 shares in the last quarter. Glenmede Trust Co. NA boosted its holdings in Merit Medical Systems by 0.6% in the third quarter. Glenmede Trust Co. NA now owns 28,637 shares of the medical instruments supplier's stock valued at $2,830,000 after acquiring an additional 170 shares in the last quarter. Captrust Financial Advisors raised its holdings in Merit Medical Systems by 2.6% in the 3rd quarter. Captrust Financial Advisors now owns 7,440 shares of the medical instruments supplier's stock worth $735,000 after purchasing an additional 187 shares in the last quarter. Finally, GAMMA Investing LLC lifted its position in shares of Merit Medical Systems by 14.7% in the 4th quarter. GAMMA Investing LLC now owns 1,494 shares of the medical instruments supplier's stock worth $144,000 after purchasing an additional 191 shares during the period. 99.66% of the stock is owned by institutional investors.

Remove Ads

Insider Buying and Selling at Merit Medical Systems

In other news, insider Brian G. Lloyd sold 25,000 shares of the company's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $99.50, for a total transaction of $2,487,500.00. Following the transaction, the insider now directly owns 38,993 shares of the company's stock, valued at $3,879,803.50. This represents a 39.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Fred P. Lampropoulos sold 31,320 shares of Merit Medical Systems stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $103.86, for a total value of $3,252,895.20. Following the completion of the sale, the chief executive officer now owns 1,086,028 shares of the company's stock, valued at $112,794,868.08. The trade was a 2.80 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 109,132 shares of company stock worth $11,139,521. 3.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on MMSI shares. Needham & Company LLC decreased their price target on shares of Merit Medical Systems from $122.00 to $116.00 and set a "buy" rating for the company in a research note on Wednesday, February 26th. Canaccord Genuity Group reduced their target price on Merit Medical Systems from $128.00 to $127.00 and set a "buy" rating on the stock in a report on Wednesday, February 26th. Raymond James raised their target price on Merit Medical Systems from $105.00 to $110.00 and gave the company an "outperform" rating in a research note on Tuesday, December 31st. Piper Sandler reaffirmed an "overweight" rating and issued a $116.00 price target (up from $114.00) on shares of Merit Medical Systems in a research note on Wednesday, January 29th. Finally, Barrington Research lowered their price objective on Merit Medical Systems from $115.00 to $111.00 and set an "outperform" rating for the company in a research report on Wednesday, February 26th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Merit Medical Systems currently has a consensus rating of "Moderate Buy" and a consensus price target of $110.78.

Merit Medical Systems Stock Down 1.7 %

Shares of NASDAQ:MMSI traded down $1.78 on Friday, hitting $99.95. 571,334 shares of the company traded hands, compared to its average volume of 582,650. The company has a market cap of $5.88 billion, a PE ratio of 49.00, a PEG ratio of 2.34 and a beta of 0.87. The stock has a 50 day simple moving average of $103.29 and a 200-day simple moving average of $100.30. Merit Medical Systems, Inc. has a 52 week low of $70.70 and a 52 week high of $111.45. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.